This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lifshitz & Miller Law Firm Announces Investigation Of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp And Texas Industries, Inc.

NEW YORK, Feb. 19, 2014 /PRNewswire/ --

Cadence Pharmaceuticals, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Cadence Pharmaceuticals, Inc. ("CADX") to Mallinckrodt plc in a cash transaction valued at $14.00 per share or approximately $1.3 billion on a fully diluted basis.

Lifshitz & Miller's investigation is focused on whether the proposed deal provides adequate value to CADX shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Chindex International, Inc.

Lifshitz & Miller  announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Chindex International, Inc. ("CHDX") to an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson for $19.00 per share in cash or approximately $369 million.

Lifshitz & Miller's investigation is focused on whether the CHDX directors are acting in shareholders best interest.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

LCA-Vision, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of LCA-Vision, Inc. ("LCA-Vision") (LCAV) to PhotoMedex, Inc. in a cash transaction valued at $5.37 per share or approximately $106.4 million.

Lifshitz & Miller's investigation is focused on whether the proposed deal provides adequate value to LCA-Vision shareholders.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs